120 related articles for article (PubMed ID: 9665192)
21. Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0).
Kotylo PK; Seo IS; Smith FO; Heerema NA; Fineberg NS; Miller K; Greene ME; Chou P; Orazi A
Am J Clin Pathol; 2000 Feb; 113(2):193-200. PubMed ID: 10664621
[TBL] [Abstract][Full Text] [Related]
22. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
23. Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).
Seshi B; Kashyap A; Bennett JM
Br J Haematol; 1992 Jul; 81(3):374-7. PubMed ID: 1382546
[TBL] [Abstract][Full Text] [Related]
24. [Classification of acute leukemias according to the first latin-american consensus conference for the immunophenotyping of leukemias].
Piedras J; Barrales-Benítez O; López-Karpovitch X
Rev Invest Clin; 2000; 52(5):524-8. PubMed ID: 11195181
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
26. Lineage commitment in biphenotypic acute leukemia.
Buccheri V; Matutes E; Dyer MJ; Catovsky D
Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
[TBL] [Abstract][Full Text] [Related]
27. [Immunocytochemistry in the diagnosis of acute myeloid leukemia (M0)].
Saito M; Kuriyama K; Nagai K; Nonaka H; Hata T; Tusima H; Tabata S; Arimura K; Souda H; Nakamura H
Rinsho Ketsueki; 1994 Nov; 35(11):1297-304. PubMed ID: 7823396
[TBL] [Abstract][Full Text] [Related]
28. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotyping of acute myeloid leukaemia: relevance of analysing different lineage-associated markers.
Lo Coco F; Pasqualetti D; Lopez M; Panzini E; Gentile A; Latagliata R; Monarca B; De Rossi G
Blut; 1989 May; 58(5):235-40. PubMed ID: 2720173
[TBL] [Abstract][Full Text] [Related]
30. Lymphoid-associated antigen expression by acute myeloid leukemia.
Launder TM; Bray RA; Stempora L; Chenggis ML; Farhi DC
Am J Clin Pathol; 1996 Aug; 106(2):185-91. PubMed ID: 8712171
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique.
Hanson CA; Gajl-Peczalska KJ; Parkin JL; Brunning RD
Blood; 1987 Jul; 70(1):83-9. PubMed ID: 3297208
[TBL] [Abstract][Full Text] [Related]
32. Acute myeloid leukemia, FAB M-1 microgranular variant: a multiparameter study.
Nguyen D; Brynes RK; Macaulay L; Kaplan B; Pinter-Brown LC
Hematol Pathol; 1989; 3(1):11-22. PubMed ID: 2545666
[TBL] [Abstract][Full Text] [Related]
33. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
34. Biological characteristics of CD7 positive acute myelogenous leukaemia.
Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
[TBL] [Abstract][Full Text] [Related]
35. Incidence of lineage promiscuity in acute myeloblastic leukemia: diagnostic implications of immunoglobulin and T-cell receptor gene rearrangement analysis and immunological phenotyping.
Oster W; König K; Ludwig WD; Ganser A; Lindemann A; Mertelsmann R; Herrmann F
Leuk Res; 1988; 12(11-12):887-95. PubMed ID: 2851073
[TBL] [Abstract][Full Text] [Related]
36. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
[TBL] [Abstract][Full Text] [Related]
37. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
[TBL] [Abstract][Full Text] [Related]
38. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia.
Parreira A; Pombo de Oliveira MS; Matutes E; Foroni L; Morilla R; Catovsky D
Br J Haematol; 1988 Jun; 69(2):219-24. PubMed ID: 3164631
[TBL] [Abstract][Full Text] [Related]
39. Electron microscopic and cytochemical studies of peroxidase-negative acute nonlymphoblastic leukemia.
Eguchi M; Mikami T; Kurosawa H; Sugita K; Furukawa T; Tsunoda S; Miura Y
Med Electron Microsc; 2001 Mar; 34(1):61-70. PubMed ID: 11479774
[TBL] [Abstract][Full Text] [Related]
40. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9.
Matutes E; Rodriguez B; Polli N; Tavares de Castro J; Parreira A; Andrews C; Griffin JD; Tindle RW; Catovsky D
Hematol Oncol; 1985; 3(3):179-86. PubMed ID: 3862640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
